NO20091261L - Framgangsmate for framstilling av pleuromutiliner - Google Patents

Framgangsmate for framstilling av pleuromutiliner

Info

Publication number
NO20091261L
NO20091261L NO20091261A NO20091261A NO20091261L NO 20091261 L NO20091261 L NO 20091261L NO 20091261 A NO20091261 A NO 20091261A NO 20091261 A NO20091261 A NO 20091261A NO 20091261 L NO20091261 L NO 20091261L
Authority
NO
Norway
Prior art keywords
preparation
sulfanyl
butyryl
acetyl
amino
Prior art date
Application number
NO20091261A
Other languages
English (en)
Other versions
NO341868B1 (no
Inventor
Ingolf Macher
Andreas Berger
Martin Decristoforo
Original Assignee
Nabriva Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics Ag filed Critical Nabriva Therapeutics Ag
Publication of NO20091261L publication Critical patent/NO20091261L/no
Publication of NO341868B1 publication Critical patent/NO341868B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Framgangsmåte for framstilling av 14-0-[(N-(3-metyl-2-amino-butyryl-piperidyl)sulanyl)acetyl]mutiliner av formel (I) anvendelig for storskala produksjon av høy-renhets produkter, og hvor karbonatomet ved piperidin-ringen festet til svovelatomet enten er i (S) konfigurasjon eller i (R) konfigurasjon, og en ny krystallinsk form av 14-0-[(N-(3-metyl-2(R)-amino-butyryl-piperidin-3(S)-yl)sulanyl)acetyl]mutilin-hydroklorid
NO20091261A 2006-10-05 2009-03-26 Framgangsmåte for framstilling av pleuromutiliner NO341868B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121852A EP1908750A1 (en) 2006-10-05 2006-10-05 Process for the preparation of pleuromutilins
PCT/AT2007/000468 WO2008040043A1 (en) 2006-10-05 2007-10-03 Process for the preparation of pleuromutilins

Publications (2)

Publication Number Publication Date
NO20091261L true NO20091261L (no) 2009-06-30
NO341868B1 NO341868B1 (no) 2018-02-12

Family

ID=37781773

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091261A NO341868B1 (no) 2006-10-05 2009-03-26 Framgangsmåte for framstilling av pleuromutiliner

Country Status (21)

Country Link
US (2) US8334389B2 (no)
EP (3) EP1908750A1 (no)
JP (1) JP5557530B2 (no)
KR (1) KR101577675B1 (no)
CN (1) CN101595090B (no)
AT (1) ATE523490T1 (no)
AU (1) AU2007304867B2 (no)
BR (1) BRPI0719205B8 (no)
CA (1) CA2665347C (no)
ES (1) ES2373341T3 (no)
HR (1) HRP20090192B1 (no)
IL (1) IL197970A (no)
MX (1) MX2009003681A (no)
MY (1) MY146357A (no)
NO (1) NO341868B1 (no)
NZ (1) NZ576034A (no)
RU (1) RU2512591C2 (no)
TW (1) TWI432416B (no)
UA (1) UA96775C2 (no)
WO (1) WO2008040043A1 (no)
ZA (1) ZA200902159B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
EP2399904A1 (en) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Process for the preparation of pleuromutilins
CN104803911B (zh) * 2014-01-23 2018-01-05 中国科学院上海药物研究所 一类截短侧耳素化合物、其药物组合物、合成方法与用途
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
GB9918037D0 (en) 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
PE20020676A1 (es) * 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
ES2295657T3 (es) * 2002-07-24 2008-04-16 Nabriva Therapeutics Forschungs Gmbh Derivados de pleuromutilina como antimicrobianos.

Also Published As

Publication number Publication date
US8334389B2 (en) 2012-12-18
HRP20090192B1 (hr) 2016-05-06
AU2007304867A1 (en) 2008-04-10
EP2069301B1 (en) 2011-09-07
CN101595090A (zh) 2009-12-02
ES2373341T3 (es) 2012-02-02
BRPI0719205B8 (pt) 2021-05-25
TWI432416B (zh) 2014-04-01
KR20090086203A (ko) 2009-08-11
JP2010505771A (ja) 2010-02-25
MY146357A (en) 2012-08-15
IL197970A0 (en) 2009-12-24
UA96775C2 (en) 2011-12-12
WO2008040043A1 (en) 2008-04-10
CA2665347C (en) 2017-02-14
TW200831461A (en) 2008-08-01
EP2272829A2 (en) 2011-01-12
ZA200902159B (en) 2010-06-30
NZ576034A (en) 2011-07-29
US20090253748A1 (en) 2009-10-08
US8624033B2 (en) 2014-01-07
IL197970A (en) 2014-09-30
ATE523490T1 (de) 2011-09-15
BRPI0719205B1 (pt) 2020-04-28
JP5557530B2 (ja) 2014-07-23
MX2009003681A (es) 2009-07-16
HK1139135A1 (en) 2010-09-10
US20130053571A1 (en) 2013-02-28
EP1908750A1 (en) 2008-04-09
EP2272829A3 (en) 2011-02-09
CA2665347A1 (en) 2008-04-10
NO341868B1 (no) 2018-02-12
KR101577675B1 (ko) 2015-12-15
EP2069301A1 (en) 2009-06-17
RU2512591C2 (ru) 2014-04-10
HRP20090192A2 (en) 2009-08-31
CN101595090B (zh) 2014-12-24
BRPI0719205A2 (pt) 2014-02-04
RU2009116945A (ru) 2010-11-10
AU2007304867B2 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
MX2012015023A (es) Derivado novedoso de nicotinamida o sal del mismo.
TW200745069A (en) Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and its use
MXPA05008619A (es) Derivados novedosos de 2-piridincarboxamida.
TW200640949A (en) Hyper-branched polymer and process for producing the same
MX2009010024A (es) Nuevo compuesto de adenina.
GB0719180D0 (en) New process
MX2009008781A (es) Derivados de ciclohexano espirociclicos.
WO2007110237A3 (en) Amide derivatives and their application for the treatment of g protein related diseases
CY1111690T1 (el) Μεθοδος για την παρασκευη δροσπιρενονης
MY148769A (en) Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
IL197970A0 (en) Process for the preparation of pleuromutilins
CY1111457T1 (el) Μεθοδοι για την παρασκευη παραγωγων ν-ισοβουτυλ-ν-(2-υδροξυ-3-αμινο-4-φαινυλβουτυλ)-ρ-νιτροβενζολοσουλφονυλαμιδιου
TW200716582A (en) Process for making a pharmaceutical compound
WO2008093700A1 (ja) トレハロース化合物、その製造方法、及び該化合物を含有する免疫賦活剤
UA74114U (ru) Производные 5-гидрокси-4-аминометил-1-циклогексил (или циклогептил)-3-алкоксикарбонилиндолов, их фармацевтически приемлемые соли, которые имеют противовирусную активность
NZ592831A (en) Stereoselective synthesis of piperidine derivatives
WO2008090819A1 (ja) 二環性プロリン化合物の製造方法
NZ589496A (en) Processes and compounds for the preparation of normorphinans
TW200738650A (en) Process for synthesis of aryloxy diaminopyrimidines
MX2008000821A (es) Nuevos derivados de piperidina.
EP1572657A4 (en) PROCESS FOR THE PREPARATION OF CHINOLONCARBOXYLATE DERIVATIVES
MY161959A (en) Continuous production of high purity carbon dioxide
HUP0302174A2 (hu) Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenilalanin (Nateglinid) és kristálymódosulatainak előállítására, valamint a G kristálymódosulata
MX2009001508A (es) Un proceso novedoso para preparar ester de acido 3-amino-5-fluoro-4-dialcoxipentanoico.
WO2008078580A1 (ja) アダマンチルエタノール類及びその製造方法